Simulations Plus Aktie [WKN: 924294 / ISIN: US8292141053]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Simulations Plus IncShs

28.02.23		Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference (Businesswire)
16.02.23		Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models (Businesswire)
09.02.23		Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool (Businesswire)
12.01.23		Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure (Businesswire)
12.01.23		Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement (Businesswire)
05.01.23		Pre-market Movers: OBLG, HKD, NUWE, RNER, ARCK… (RTTNews)
04.01.23		Simulations Plus Reports First Quarter Fiscal 2023 Financial Results (Businesswire)
19.12.22		Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
15.11.22		Simulations Plus and the University of Bath Awarded New FDA Grant (Businesswire)
10.11.22		Gustavo Mendes Lima Santos Joins the Simulations Plus Regulatory Fellowship Program (Businesswire)
03.11.22		Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code (Businesswire)
02.11.22		Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products (Businesswire)
20.10.22		Simulations Plus Announces Cash Dividend (Businesswire)
12.10.22		Simulations Plus Releases GastroPlus® Version 9.8.3 (Businesswire)
11.10.22		Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
14.09.22		Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference (Businesswire)
07.09.22		Simulations Plus to Present at Baird 2022 Global Healthcare Conference (Businesswire)
31.08.22		Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease (Businesswire)
04.08.22		Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa) (Businesswire)
26.07.22		Simulations Plus Presented New Scientific Developments at PAGE 2022 (Businesswire)
21.07.22		Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer (Businesswire)
14.07.22		Simulations Plus Realizes Early Success with its Concierge Program (Businesswire)
06.07.22		Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results (Businesswire)
30.06.22		Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop (Businesswire)
23.06.22		Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment (Businesswire)
21.06.22		Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
26.05.22		Simulations Plus Releases ADMET Predictor Version 10.4 (X.4) (Businesswire)
05.05.22		U.S. FDA Renews Annual DILIsym Software Licenses for 2022 (Businesswire)
28.04.22		Simulations Plus Successfully Delivers FDA-Funded Project (Businesswire)
21.04.22		Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software (Businesswire)
19.04.22		Simulations Plus to Present at the Berenberg Discover AI Seminar (Businesswire)
29.03.22		Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software (Businesswire)
24.03.22		Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference (Businesswire)
22.03.22		Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
17.03.22		Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders (Businesswire)
10.03.22		Simulations Plus Releases MembranePlus 3.0 (Businesswire)
08.03.22		Simulations Plus to Present at Oppenheimer Annual Healthcare Conference (Businesswire)
02.03.22		Simulations Plus to Present at Raymond James Institutional Investors Conference (Businesswire)
08.02.22		Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Businesswire)
20.01.22		Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model (Businesswire)
30.11.21		Simulations Plus celebrates 25-year anniversary with $25,000 gift to nonprofit Dispensary of Hope (PR Newswire)
08.07.21		Simulations Plus Celebrates 25 Years in Business (Businesswire)
28.06.21		Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call (Businesswire)
17.06.21		Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF) (Businesswire)
27.05.21		Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference (Businesswire)
13.05.21		Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media Conference (Businesswire)
12.05.21		Simulations Plus Uplisted to The Nasdaq Global Select Market® (Businesswire)
27.04.21		Simulations Plus Releases ADMET Predictor® (X.2) (Businesswire)
20.04.21		U.S. FDA Renews Licenses of DILIsym Software (Businesswire)
07.04.21		Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Ripple auf dem Weg zu 100 US-Dollar in 2025?

Krypto-Rekorde voraus: Wall Street sieht Bitcoin bei 200.000 US-Dollar

EQS-Adhoc: STRABAG SE CEO Klemens Haselsteiner passed away completely unexpectedly

Ripple Kurs Prognose: 10 US-Dollar bis Ende des Jahres?

Diese Aktien empfehlen Experten zu kaufen

Trump ruft eigenen Krypto-Coin "$TRUMP" ins Leben - Kryptocoin auch für Melania

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	20.01.2025 14:30
Kaufwert:	EUR
	Hinzufügen Speichern